Trading Signals: LGND Stock Price Prediction and Forecast (Mon. Aug. 10, 2015 - Wed. Sep. 27, 2023)(Ligand Pharmaceuticals Inc)
| LGND latest price $148.2000 (-1.3%) ($148.2000 - $148.2000) on Fri. Feb. 26, 2021. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 4.79% (three month average) | RSI | 24 | Latest Price | $148.2000(-1.3%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | LGND advances 0.8% a day on average for past five trading days. | Weekly Trend | LGND declines -15.6% a week on average for past two weeks. | Market Behavior | Value stocks sell-off for large cap. Rotation from value to growth for small cap. | Correlated ETFs | Broad market will support LGND advance at 0% a week (0% probability) IBB(59%) IWO(58%) IWM(54%) IWC(53%) XBI(53%) | Factors Impacting LGND price | LGND will decline at least -2.395% in a week (0% probabilities). VIXM(-27%) UUP(-18%) VXX(-17%) UNG(-3%) USO(-0%) | Explanation | The rally is not sustainable and not supported by the broad market. | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -2.395% (StdDev 4.79%) | Hourly BBV | 0.6 () | Intraday Trend | 0% | | | |
|
1 - 5 Day Possible Target | $119.49(-19.37%) | Inflection Point | Yes | Resistance Level | $169.42 | 5 Day Moving Average | $145.3(2%) | 10 Day Moving Average | $149.25(-0.7%) | 20 Day Moving Average | $169.42(-12.53%) | To recent high | -31.3% | To recent low | 77.5% | Market Cap | $2.382b | | | | Ligand Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the development and acquisition of technologies that help pharmaceutical companies to discover and develop medicines. Its products include evomela, IV voriconazole, duavee, viviant/conbriza, nexterone, and noxafil-IV. The company was founded by Ronald M. Evans in 1987 and is headquartered in San Diego, CA. |